January 2018 WGM New Orleans; Jan 27 to Feb 8

• Back to Patient Care

• Back to Patient Care Work Group meeting Agenda and Draft Minutes

• Back to 2018 PCWG WGM Agenda and Minutes

New Orleans WGM - Jan 2018 Patient Care WG Meeting Draft/Approved agenda:
NOTE- to view WGM meeting minutes: follow the link for each quarter in Event column of the agenda below

Agenda

Day	Time	Qtr	Room	#	Event	Host	Joining	Chair	Scribe
Sunday Jan 28	AM	Q1
		Q2
	PM	Q3
		Q4
Day	Time		Room	#	Event	Host	Joining	Chair	Scribe
Monday Jan 29	AM	Q1	Windsor - 3rd Floor	20	* Agenda: PCWG Admin * DMP review * PCWG Jan 2018 WGM Monday Q1 Meeting notes	Patient Care		Michelle	Michael Tan
		Q2	Jefferson Ballroom - 3rd Floor	20	GF#12676 Guidance request for GP SOAP in FHIR (Alexander Henket) - https://chat.fhir.org/#narrow/stream/implementers/topic/ClinicalImpression Dec 14 SD Minutes 2017-11-30_Patient_Care_FHIR_Call#Clinical_Note ClinicalNote_FHIR_Resource_Proposal Past tracker, GF#8780, A Home for Unstructured Clinical Content Health Concern - tracking/linking heterogeneous resources Clinical Impression FHIR resource maturity	Patient Care	Accepted: SD, FHIR-I,EC	Michael	Jay
		Q2b	TBD	NA	Podiatry Functional Profile Head	EHR		NA	TBD
	PM	Q3	Jefferson Ballroom - 3rd Floor	NA	* Agenda: Mega Report Out * Meeting notes - refer to EHRWG meeting minutes * PCWG presentation slide deck: insert here	EHR	Accepted: Patient Care	NA	Jay/Laura - Present; Emma - Scribe
		Q4	Commerce - 3rd Floor	NA	* Agenda: Joint Session with FHIR & OO on FHIR workflow	FHIR-I	Accepted: PC	NA	Emma
Day	Time		Room	#	Event	Host	Joining	Chair	Scribe
Tuesday Jan 30	AM	Q1	Jefferson Ballroom - 3rd Floor	40	* Agenda: FHIR/PCWG - CIMI - Skin Care model meeting * Meeting notes	Patient Care	Accepted: CIMI, EC	Jay	Laura
		Q2	Magazine - 3rd Floor	20	* Agenda: FHIR Change requests * PHER will join PC to discuss the new OccupationalData resource * Meeting notes:	Patient Care	Declined: FHIR-I	Michelle	Michelle/Emma
	PM	lunch	?
		Q3a	Magazine - 3rd Floor	20	* Agenda: FHIR Admin and Change requests * Nutrition Transitions of Care IG *Meeting notes:	Patient Care	Accepted: FHIR-I	Michelle	Michelle
		Q3b	TBD	NA	* Agenda: SD Hosted Joint Quarter: C-CDA Score Card; Advance Directive Templates * Meeting notes:	SD		NA	Emma
		Q4	Jefferson Ballroom - 3rd Floor	40	* Agenda: * Negation * harmonization across specification families * other vocab topics * Michael T to Pharmacy/BRR re medication knowledge * Meeting notes:	Patient Care	Accepted: CIMI, Vocab, Clin Genomics, SD, OO	Jay	Emma
Day	Time		Room	#	Event	Host	Joining	Chair	Scribe
Wednesday Jan 31	AM	Q1	TBD	20	* Agenda: FHIR Change requests - with OO representatives GF#12633 Split Procedure into Procedure and ProcedureStatement (Lloyd McKenzie) Zulip chat asking for implementer feedback: https://chat.fhir.org/#narrow/stream/implementers/topic/Procedure.20vs.20ProcedureStatement Dave commented that there is relevance for ProcedureStatement in context of CarePlan activities (Activity Statements where the activity is a procedure) ServiceRequest - trackers and open issues Procedure/Diagnostic Report - picking up this stream: http://lists.hl7.org/read/messages?id=319935 Seems to imply using DR to create a ProcedureReport ( e.g. a SX Report, Dental Report, etc) Need to clarify the intent in order to update Proc and DR's scope and boundaries Update on ClinicalNotes from Mon Q2 discussion with SD, FHIR-I, and PC. Other areas of common interest Meeting notes	Patient Care	Accepted: OO	Michelle	Emma
		Q2	TBD	NA	* Agenda: PA hosted joint meeting -- Episode of Care; Care Team * Meeting notes:	PA	Accepted: PC	NA	Michelle / Michael
	PM	lunch	TBD	20	* Agenda: Clinician-On-FHIR Preperation meeting * Meeting notes	Patient Care		Russ	Emma
		Q3	TBD	NA	* Agenda: Focus on BiologicallyDerivedProduct GF#12673 How to handle HCT/TP GF#12993 Please Create a NonMedicationAdministration object or an Administration object GF#13047 Add DosageInstructions to Procedure Meeting notes:	OO	Accepted: PC Invited: CQI, CDS, Pharmacy, OO, PA, FHIR-I	NA	Michelle
		Q3b	TBD	NA	* Agenda: Common Clinical Registry Framework * Meeting notes:	CIC	Accepted: PC Invited: CQI	NA	Laura
		Q4	TBD	30	* Agenda: Allergy/Intolerance topic meeting. Drug list approach & Issues. Allergy resource maturity * Meeting notes:	Patient Care	Accepted: Pharmacy, Vocab	Jay	Michael T
Day	Time		Room	#	Event	Host	Joining	Chair	Scribe
Thursday Feb 1	AM	Q1a	TBD	35	Care Plan -invite FHIR, Structured Docs, Pharmacy Evelyn Gallego Care Plan Survey - Implementations, pilots, proposals CDA HL7 C-CDA 2.1 Care Plan Document Template - Lisa Nelson HL7 CDA R2 Personal Advanced Care Plan Document - Lisa Nelson IHE QRPH Early Hearing Detection and Intervention (EHDI) Plan of Care- Lisa Nelson Patient Care Care Plan Project HL7 Care Plan Domain Analysis Model/FHIR Harmonization - Laura Heermann/Emma Jones HL7 Care Coordination Services (CCS) functional model - LH/EJ Child with special needs (Mike Padula) HL7 FHIR Care Plan Resource - LH/EJ IHE PCC Dynamic Care Planning Profile- EJ Update: PlanDefinition/ActivityDefinition Care Team Managment Profile - EJ HL7 Clinical Oncology Treatment Plan and Summary - Jeff Brown/Gay Dolin NCPDP/HL7 Pharmacist Care Plan - Shelly Spiro Learning Health Systems Care team project update (Russ/Laura/Emma) Bidirectional Social Services Referrals Others Check the minutes ....	Patient Care	Accepted: Pharmacy, LHS, SD	Laura	Emma
		Q1b	TDB	NA	Joint meeting with OO, CDS, PC, Templates (Note: editorial resp for V2 - Chapters 11 & 12)	OO	Accepted: Patient Care	NA	Rob H
		Q2	TBD	25	Joint meeting with SD and Templates Proposed agenda: Template update (Template co-chair/rep) Template versioning; Structured Doc/CDA update (SDWG co-chairs) Patient Care update: Allergy/Intolerance harmonization Care Team (PC with LHS) Clinical Status Value-set - C-CDA and FHIR	Patient Care	Accepted: SD Invited: Templates	Laura/Rob H/Jay	Emma
	PM	lunch	TBD	10	Co-Chair Admin Meeting	Patient Care		Michelle	Michelle
		Q3a	TBD	20	*Agenda: FHIR Change Requests related to AdverseEvent GF#13302 Vocabulary issues with AdverseEvent GF#13698 AdverseEvent.suspectedEntity.instance should allow CodeableConcept GF#11021 Increase cardinality of substance and make certainty relation to substance, not reaction - 2016-09 core #40 GF#14238 AdverseEvent.suspectEntity.instance should be expanded to include the Immunization resource (Craig Newman) - also related to GF#14152 Meeting notes: - Need to invite CIMI	Patient Care	Accepted: BRR, FHIR-I	Michelle	Michelle
		Q3b	TBD	NA	Joint meeting with CS, OO, and PC. * Meeting notes - PC Not Needed anymore	CS	Accepted: Patient Care	NA	NA
		Q4	TBD	NA	* Agenda: LHS - CareTeam DAM ONC/CMS eLTSS Project GF#14334 allow careteam.participant,member to reference a Practitioner role GF#12509 CareTeam participant * Meeting notes	LHS	Patient Care	NA	Emma
Day	Time		Room		Event	Host	Joining	Chair	Scribe
Friday Feb 2	AM	Q0			ClinFHIR - LForms			Laura	Emma
		Q1			ClinFHIR
		Q2			ClinFHIR
	PM	Q3			ClinFHIR
		Q4			No meeting

Meetings

Monday Q2

• GF#12676 Guidance request for GP SOAP in FHIR (Alexander Henket) -
  • https://chat.fhir.org/#narrow/stream/implementers/topic/ClinicalImpression
  • Dec 14 SD Minutes
  • 2017-11-30_Patient_Care_FHIR_Call#Clinical_Note
  • ClinicalNote_FHIR_Resource_Proposal
  • Past tracker, GF#8780, A Home for Unstructured Clinical Content
• Health Concern - tracking/linking heterogeneous resources
• Clinical Impression FHIR resource maturity

Tuesday Q1

• Skin and wound CIMI model
• DAM alignment
• Terminologies

Tuesday Q4

Agenda

1. Negation
   1. capture cases well-represented
   2. usage cases needed
2. Harmonization
   1. Does PC specify value sets, or only semantics of value sets?
   2. Is PC responsible for maintenance and harmonization of value sets?
   3. Can PC suggest FHIR use SD values, or vice versa?
   4. Should FHIR data type policy trump interoperability?
   5. Does legacy momentum count? I.e., should C-CDA have more weight than FHIR?
   6. Or realm? I.e., should FHIR have more weight than C-CDA?
   7. Should PC simply specify values in the DAM and expect SD & FHIR to conform?
   8. Or maintain concept maps for divergent value sets?
   9. Who should be in the discussion